Drug Shortage Report for VIRAZOLE
| Report ID | 155206 |
| Drug Identification Number | 02170140 |
| Brand name | VIRAZOLE |
| Common or Proper name | VIRAZOLE |
| Company Name | BAUSCH HEALTH, CANADA INC. |
| Market Status | MARKETED |
| Active Ingredient(s) | RIBAVIRIN |
| Strength(s) | 6G |
| Dosage form(s) | POWDER FOR SOLUTION AEROSOL |
| Route of administration | INHALATION INHALATION |
| Packaging size | 6G VIAL |
| ATC code | J05AP |
| ATC description | |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | |
| Actual start date | 2022-02-07 |
| Estimated end date | Unknown |
| Actual end date | 2022-08-01 |
| Shortage status | Resolved |
| Updated date | 2022-09-27 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2150 BOUL. ST-ELZEAR OUEST LAVAL, QUEBEC CANADA H7L 4A8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2022-09-27 | English | Compare |
| v3 | 2022-03-17 | English | Compare |
| v2 | 2022-02-17 | French | Compare |
| v1 | 2022-02-17 | English | Compare |
Showing 1 to 4 of 4